CORC  > 山东大学
Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-gamma pathway
Wang, Hong-Yuan; Zhang, Ying; Zhou, Yue; Lu, Yu-Yin; Wang, Wen-Fang; Xin, Ming; Guo, Xiu-Li
刊名BIOMEDICINE & PHARMACOTHERAPY
2016
卷号83页码:349-361
关键词Rosiglitazone Vincristine Cell proliferation and apoptosis Cell cycle Drug resistance reversal PTEN/PI3K/AKT Oral epidermoid carcinoma
DOI10.1016/j.biopha.2016.06.047
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4710922
专题山东大学
作者单位Shandong Univ, Sch Pharmaceut Sci, Dept Pharmacol, Key L
推荐引用方式
GB/T 7714
Wang, Hong-Yuan,Zhang, Ying,Zhou, Yue,et al. Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-gamma pathway[J]. BIOMEDICINE & PHARMACOTHERAPY,2016,83:349-361.
APA Wang, Hong-Yuan.,Zhang, Ying.,Zhou, Yue.,Lu, Yu-Yin.,Wang, Wen-Fang.,...&Guo, Xiu-Li.(2016).Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-gamma pathway.BIOMEDICINE & PHARMACOTHERAPY,83,349-361.
MLA Wang, Hong-Yuan,et al."Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-gamma pathway".BIOMEDICINE & PHARMACOTHERAPY 83(2016):349-361.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace